Expression of prox1, lymphatic endothelial nuclear transcription factor, in kaposiform hemangioendothelioma and tufted angioma

American Journal of Surgical Pathology

Volumn 34, Issue 11, 2010, Pages 1563-1573

  Le Huu, Aude Rimella ^a,b   Jokinen, Chris H ^c   Ruben, Brian P ^c   Mihm, Martin C ^d   Weiss, Sharon W ^e   North, Paula E ^f   Dadras, Soheil S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

CD31; CD34; infantile hemangioma; kaposiform hemangioendothelioma; LYVE 1; podoplanin (D2 40); Prox1; tufted angioma

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; HOMEODOMAIN PROTEIN; LYMPHATIC VESSEL ENDOTHELIAL HA RECEPTOR 1 PROTEIN, HUMAN; LYMPHATIC VESSEL ENDOTHELIAL HA RECEPTOR-1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PDPN PROTEIN, HUMAN; PROSPERO RELATED HOMEOBOX 1 PROTEIN; PROSPERO-RELATED HOMEOBOX 1 PROTEIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; VESICULAR TRANSPORT PROTEIN;

ADOLESCENT; ARTICLE; CELL NUCLEUS; CHEMISTRY; CHILD; CLASSIFICATION; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; METABOLISM; PREDICTION AND FORECASTING; PRESCHOOL CHILD; PYOGENIC GRANULOMA; SKIN TUMOR; SOFT TISSUE TUMOR;

ADOLESCENT; ANTIGENS, CD31; ANTIGENS, CD34; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; CYTOPLASM; DIAGNOSIS, DIFFERENTIAL; GRANULOMA, PYOGENIC; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; MEMBRANE GLYCOPROTEINS; PREDICTIVE VALUE OF TESTS; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 78049528230     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181f6076f     Document Type: Article

References (44)

1. Alvarez-Mendoza A, Lourdes TS, Ridaura-Sanz C, et al. Histo-pathology of vascular lesions found in Kasabach-Merritt syndrome: review based on 13 cases. Pediatr Dev Pathol. 2000;3:556-560.
2. Arai E, Shimizu K, Hirose T, et al. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma. J Cutan Pathol. 2006; 33:492-497.
3. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144:789-801.
4. Belecky-Adams T, Tomarev S, Li HS, et al. Pax-6, Prox 1, and Chx10 homeobox gene expression correlates with phenotypic fate of retinal precursor cells. Invest Ophthalmol Vis Sci. 1997;38:1293-1303.
5. Brasanac D, Janic D, Boricic I, et al. Retroperitoneal kaposiform hemangioendothelioma with tufted angioma-like features in an infant with Kasabach-Merritt syndrome. Pathol Int. 2003;53:627.
6. Breiteneder-Geleff S, Matsui K, Soleiman A, et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol. 1997;151:1141-1152.
7. Chu CY, Hsiano CH, Chiu HC. Transformation between kaposi-form hemangioendothelioma and tufted angioma. Dermatology. 2003;206:334.
8. Cooper JG, Edwards SL, Holmes JD. Kaposiform haemangioen-dothelioma: case report and review of the literature. Br J Plast Surg. 2002;55:163-165.
9. Dadras SS, Detmar M. Angiogenesis and lymphangiogenesis of skin cancers. Hematol Oncol Clin North Am. 2004;18:1059-1070, viii.
10. Dadras SS, North PE, Bertoncini J, et al. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol. 2004;17:1068-1079.
11. Dadras SS, Skrzypek A, Nguyen L, et al. Prox-1 promotes invasion of kaposiform hemangioendotheliomas. J Invest Dermatol. 2008; 128:2798-2806.
12. Debelenko LV, Perez-Atayde AR, Mulliken JB, et al. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol. 2005;18:1454-1460.
13. Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol. 1997;24:701-710.
14. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1998;13:375-422.
15. Enjolras O, Wassef M, Mazoyer E. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr. 1997;130: 631-640.
16. Enjolras O, Mulliken JB, Wassef M. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol. 2000;42:225-235.
17. Folpe AL, Veikkola T, Valtola R, et al. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol. 2000;13:180-185.
18. Galambos C, Nodit L. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Pediatr Dev Pathol. 2005;8:181-189.
19. Gianotti R, Gelmetti C, Alessi E. Congenital cutaneous multifocal kaposiform hemangioendothelioma. Am J Dermatopathol. 1999;21: 557-561.
20. Hong YK, Harvey N, Noh YH, et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn. 2002;225:351-357.
21. Hong YK, Foreman K, Shin JW, et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet. 2004;36:683-685.
22. Kahn JH, Bailey D, Marks A. Monoclonal antibody D2, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434.
23. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endo-thelium during development. Proc Natl Acad Sci \USA. 1995;92: 3566-3570.
24. Lavado A, Oliver G. Prox1 expression patterns in the developing and adult murine brain. Dev Dyn. 2007;236:518-524.
25. Lyons LL, North PE, Mac-Moune Lai F. Kaposiform hemangioen-dothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile heman-gioma. Am J Surg Pathol. 2004;28:559-568.
26. Miettinen M. Diagnostic Soft Tissue Pathology. Hong Kong: Churchill Livingston; 2003.
27. North PE, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31:11-22.
28. North PE, Waner M, Buckmiller L, et al. Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol. 2006;15:303-317.
29. Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 2002;16:773-783.
30. Oliver G, Sosa-Pineda B, Geisendorf S, et al. Prox 1, a prospero-related homeobox gene expressed during mouse development. Mech Dev. 1994;44:3-16.
31. Papoutsi M, Tomarev SI, Eichmann A, et al. Endogenous origin of the lymphatics in the avian chorioallantoic membrane. Dev Dyn. 2001;222:238-251.
32. Petrova TV, Makinen T, Makela TP, et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeo-box transcription factor. Embo J. 2002;21:4593-4599.
33. Powell J. Update on hemangiomas and vascular malformations. Curr Opin Pediatr. 1999;11:457.
34. Reis RM, Reis-Filho JS, Longatto Filho A, et al. Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors. Pathol Res Pract. 2005;201:771-776.
35. Requena L, Sangueza OP. Cutaneous vascular proliferation. II. Hyperplasias and benign neoplasms. J Am Acad Dermatol. 1997;37: 887-919.
36. Rodriguez-Niedenfuhr M, Papoutsi M, Christ B, et al. Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol. 2002;204: 399-406.
37. Sarkar M, Mulliken JB, Kozakewich HP. Thrombocyto-penic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100: 1377-1386.
38. Schacht V, Dadras SS, Johnson LA, et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glyco-protein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005;166:913-921.
39. Weiss S, Goldblum J. Enzinger and Weiss's Soft Tissue Tumors. St Louis: Mosby; 2001.
40. Werner JA, Dunne AA, FoIz BJ. Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol. 2001;258:141-149.
41. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;98:769-778.
42. Wigle JT, Chowdhury K, Gruss P, et al. Prox1 function is crucial for mouse lens-fibre elongation. Nat Genet. 1999;21:318-322.
43. Xu H, Edwards JR, Espinosa O, et al. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Hum Pathol. 2004;35:857-861.
44. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangio-endothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomato-sis. Am J Surg Pathol. 1993;17:321-328.